We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Angelini Pharma

News List

Angelini Pharma acquires Arvelle Therapeutics for $960 million expresspharma
January 05, 2021
Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the European Economic Area.
Ovid, Angelini Pharma Announce Agreement for OV101 americanpharmaceuticalreview
July 22, 2020
Ovid Therapeutics and Angelini Pharma announced an agreement in which Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 (gaboxadol) for the potential treatment of Angelman syndrome in the European Union, other countries..
Angelini Pharma Acquires ThermaCare from GSK americanpharmaceuticalreview
March 11, 2020
Angelini Pharma has acquired the ThermaCare® global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia.